LUNA:VIE
H Lundbeck A/S Class A
7,72 €
arrow_upward
+1,45%(+0,11) 1K
13-noy, 17:36:00 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoLUNA tikeri uchun statistika yaratilmoqda...
Ochish
7,75 €
Yuqori
7,80 €
Past
7,55 €
Bozor kapitali
58,87Â mlrd
Oʻrtacha hajm
143,00
Hajmi
17,00
52 haftalik eng yuqori
8,17 €
52 haftalik eng past
4,22 €
Xodimlar soni
5Â ming
Ochish
7,75 €
Yuqori
7,80 €
Past
7,55 €
Bozor kapitali
58,87Â mlrd
Oʻrtacha hajm
143,00
Hajmi
17,00
52 haftalik eng yuqori
8,17 €
52 haftalik eng past
4,22 €
Xodimlar soni
5Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
TradingKey
·
36 daqiqa oldin
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
TradingView
·
7 soat oldin
SpaceX's S&P 500 bid gets new life as Elon Musk pitches Tesla merger
24/7 Wall St.
·
3 soat oldin
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Traders Union
·
7 soat oldin
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profil
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
H Lundbeck A/S Class A haqida
CEOCharl Van Zyl
Xodimlar soni5Â ming
Asos solingan1915
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytlundbeck.com